Lung cancer is one of the most rapidly growing malignancies in terms of morbidity and
mortality. Although traditional treatments have been used for more than 50 years, it is still far …

Background: Lung cancer is one of the most fatal chronic diseases in the field of respiratory
medicine. The purpose of this paper is to address the side effects of conventional treatment …

Degenerative diseases are results of deterioration of cells and tissues with aging either by
unhealthy lifestyle or normal senescence. The degenerative disease likely affects central …

Nanotechnology is an emerging science with the potential to create new materials and
strategies involving manipulation of matter at the nanometer scale (< 100 nm). With size …

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are serious lung
injuries caused by various factors, leading to increased permeability of the alveolar-capillary …

Asthma is a serious global public health concern. Airway neutrophilic inflammation is closely
related to severe asthma, for which effective and safe therapies remain to be developed …

Background Uncontrolled inflammation is a central problem for many respiratory diseases.
The development of potent, targeted anti-inflammatory therapies to reduce lung …

Engineered nanoparticles (NPs) offer site-specific delivery, deposition and cellular uptake
due to their unique physicochemical properties and were shown to modulate immune …

Viruses are a major cause of mortality and socio-economic downfall despite the plethora of
biopharmaceuticals designed for their eradication. Conventional antiviral therapies are often …

Lung cancer is managed using conventional therapies, including chemotherapy, radiation
therapy, or a combination of both. Each of these therapies has its own limitations, such as …